Communiqués Biodesix, Inc.

Actions

BDSX

US09075X1081

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
1,53 ^USD	+2,00 %		-4,97 %	-16,85 %

21/05	Biodesix, Inc. présentera de nouvelles données sur le test Nodify XL2 lors de la réunion annuelle de l'ATS 2024	CI
13/05	BIODESIX, INC. : TD Cowen à l'achat	ZM

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Biodesix Named to Inc. Magazine's 2024 Best Workplaces	19/06	AQ
Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”	18/06	BU
Biodesix to Participate in Two Investor Conferences in June	28/05	BU
Biodesix to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting	22/05	AQ
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting	21/05	BU
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management	08/05	BU
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference	07/05	BU
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024	24/04	BU
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting	09/04	BU
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement	08/04	AQ
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement	05/04	BU
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center	25/03	BU
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights	04/03	AQ
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights	01/03	BU
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference	26/02	BU
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024	16/02	BU
Biodesix : New Financial Obligation - Form 8-K	20/12	PU
Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method	15/11	AQ
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method	14/11	BU
Biodesix to Participate in Two Upcoming Investor Conferences in November	09/11	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Biodesix, Inc.

Actions

BDSX

US09075X1081

Communiqués

Filtres